Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer
International Ophthalmology, vol.29, no.2, pp.123-125, 2009 (Scopus)
- Publication Type: Article / Article
- Volume: 29 Issue: 2
- Publication Date: 2009
- Doi Number: 10.1007/s10792-007-9180-4
- Journal Name: International Ophthalmology
- Journal Indexes: Scopus
- Page Numbers: pp.123-125
- Keywords: Corneal neovascularization, Corneal transplant, Cyclosporine 0.05%, Fungal corneal ulcer
- Ondokuz Mayıs University Affiliated: Yes
Abstract
Purpose: To report regression of corneal stromal neovascularizations with the use of topical cyclosporine 0.05% in a corneal transplant patient performed for fungal corneal ulcer. Design Case report. Methods: A 14-year-old boy treated for fungal corneal ulceration developed 360° corneal stromal neovascularization peroperatively. Topical cyclosporine 0.05% was used to decrease the risk of rejection. Results: The neovascularizations regressed totally within 2 months and no signs of graft rejection were present at 6 months follow up. Conclusion: Topical cyclosporine 0.05% may result in regression of stromal corneal neovascularizations and help to reduce the risk of graft rejection in selected cases. © Springer Science+Business Media B.V. 2007.